Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, October 21 2014 6:44am ET - U.S. Markets open in 2 hours and 46 minutes.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Delivery News
Latest News
Monday, Oct 20, 2014
·VALEANT PHARMACEUTICALS INTL (VRX) Earnings Report: Q3 2014 Conference Call Transcript
at TheStreet.com - Mon 4:45 pm ET
·PetMed’s results hurt by shortened flea and tick season — seriously?
at MarketWatch - Mon 4:28 pm ET
·Allergan files rebuttal to Valeant earnings
at MarketWatch - Mon 3:13 pm ET
·Jim Cramer: Valeant Pharmaceuticals and Allergan Are Winners
at TheStreet.com - Mon 11:45 am ET
·[$$] PetMed Posts Lower Earnings
at The Wall Street Journal Online - Mon 11:43 am ET
·[$$] Valeant Pushes Business Strength
at The Wall Street Journal Online - Mon 10:48 am ET
·Strong On High Volume: Valeant Pharmaceuticals International (VRX)
at TheStreet.com - Mon 10:02 am ET
·[video] Cramer's Stop Trading: Valeant & Allergan
at CNBC - Mon 9:55 am ET
·PetMed Express D/B/A 1-800-PetMeds Announces Its Second Quarter Financial Results and Its $0.17 Per Share Quarterly Dividend
GlobeNewswire - Mon 8:00 am ET
·[video] Valeant's bid for Allergan
at CNBC - Mon 7:22 am ET
·[video] Valiant effort by Valeant, Q3 beats estimates
at CNBC - Mon 7:21 am ET
·Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results
CNW Group - Mon 7:00 am ET
·Valeant Pharmaceuticals Reports Third Quarter 2014 Financial Results
PR Newswire - Mon 7:00 am ET
Friday, Oct 17, 2014
·[video] Faber Report: Allergan takeover battle
at CNBC - Fri Oct 17
Thursday, Oct 16, 2014
·[video] Ackman: Allergan tried to manipulate Valeant stock
at CNBC - Thu Oct 16
·Bio-Path Holdings, Inc. (Nasdaq: BPTH) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Thu Oct 16
·Why PetMed Express (PETS) Might Surprise This Earnings Season
Zacks.com - Thu Oct 16
·Acura Pharmaceuticals Provides Update on Its Hydrocodone Bitartrate With Acetaminophen Tablets Development
Marketwire - Thu Oct 16
Wednesday, Oct 15, 2014
·Intellipharmaceutics Announces Third Quarter 2014 Results
GlobeNewswire - Wed Oct 15
·Valeant Pharmaceuticals To Announce 2014 Third Quarter Results On October 20, 2014
PR Newswire - Wed Oct 15
More Latest News...
Sponsor Results
Microencapsulation
Custom API encapsulation, small molecules and biologics, cGMP
www.phosphorex.com
Invest In Oil Royalties
Long Reserve Life. 10%+ Annual ROI. 1031 Exchangeable W/ Tax Incentives
www.cruderoyalties.com
Invest In Oil & Gas Wells
Earn Direct Oil&Gas Well Ownership. Low Investment & Large Potential!
www.crude.com/Invest
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?